prof. dr. W. (Wijnand) Helfrich
Telephone:
E-mail:
w.helfrich umcg.nl
Research
Publications
A light-responsive liposomal agent for MRI contrast enhancement and monitoring of cargo delivery
Reeßing, F., Stuart, M. C. A., Samplonius, D. F., Dierckx, R. A. J. O., Feringa, B. L., Helfrich, W. & Szymanski, W., 16-Sep-2019, In : Chemical communications (Cambridge, England). 55, 72, p. 10784-10787 4 p.Research output: Contribution to journal › Article › Academic › peer-review
Bispecific Antibody Approach for Improved Melanoma-Selective PD-L1 Immune Checkpoint Blockade
Koopmans, I., Hendriks, M. A. J. M., van Ginkel, R. J., Samplonius, D. F., Bremer, E. & Helfrich, W., Nov-2019, In : Journal of Investigative Dermatology. 139, 11, p. 2343-+ 12 p.Research output: Contribution to journal › Article › Academic › peer-review
Targeting the messengers of death: the advent of selective activation of apoptosis for cancer therapy.
Bremer, E. & Helfrich, W., 1-Jan-2006, In : Discovery medicine. 6, 33, p. 113-117 5 p.Research output: Contribution to journal › Article › Academic › peer-review
Development of Bispecific Antibody Derivatives for Cancer Immunotherapy
He, Y., Helfrich, W. & Bremer, E., 2019, Cancer Immunosurveillance: Methods and Protocols. Humana Press, p. 335-347 13 p. (Methods in Molecular Biology).Research output: Chapter in Book/Report/Conference proceeding › Chapter › Academic › peer-review
Quantitative proteomics analysis identifies MUC1 as an effect sensor of EGFR inhibition
de Boer, H. R., Pool, M., Joosten, E., Everts, M., Samplonius, D. F., Helfrich, W., Groen, H. J. M., van Cooten, S., Fusetti, F., Fehrmann, R. S. N., de Vries, E. G. E. & van Vugt, M. A. T. M., 28-Feb-2019, In : ONCOGENE. 38, 9, p. 1477-1488 12 p.Research output: Contribution to journal › Article › Academic › peer-review
ID: 82686